Navigation Links
NeuroFocus Announces World's First Wireless Full-Brain EEG Measurement Headset: Mynd™

NEW YORK, March 21, 2011 /PRNewswire/ -- NeuroFocus unveiled the first dry, wireless headset designed to capture brainwave activity across the full brain today at the 75th Annual Advertising Research Foundation conference being held at the Marriott Marquis in New York.  Developed over the last three years, Mynd™ combines medical-grade technology with mobility, leapfrogging current neurological testing methods.  For the first time, market researchers will be able to capture the highest quality data on consumers' deep subconscious responses in real time wirelessly, revolutionizing mobile in-store market research and media consumption at home.  NeuroFocus has also commenced building the world's first full-brain home panels in addition to its labs. The European Tools for Brain-Computer Interaction consortium (TOBI) will utilize Mynd as their core platform to develop practical, medical-grade technology that will improve the quality of life for people with neurological disabilities.  NeuroFocus is offering the opportunity to demo Mynd at Booth #514 at the conference.


"While developing Mynd, we focused on achieving medical-grade scientific precision along with extraordinary ease of use and aesthetics.  This neuromarketing breakthrough provides new opportunities for our clients to gain critical knowledge and insights into how consumers perceive their brands, products, packaging, in-store marketing, and advertising at the deep subconscious level in real time," said Dr. A. K. Pradeep, Chief Executive Officer of NeuroFocus.  "We are also delighted that TOBI has embraced our approach by adopting our wireless headset for their research in patients with devastating neurological disorders such as spinal cord damage and stroke," continued Dr. Pradeep.

By gaining mobility without sacrificing medical-grade technology, the lightweight, sleekly-designed Mynd opens up new testing environments to consumers beyond the lab, such as the home, outdoor venues, movie theaters, shopping malls, and auditoriums with data being streamed to platforms, including the iPad, iPhone and other smart devices.

Product Highlights

Mynd has undergone rigorous development and testing procedures for three years. The standards set for the device to meet included performance levels as accurate and reliable as gel-based, wired EEG systems used in clinical settings for a host of neurological disorders, as well as high durability and serviceability.  

Key highlights of Mynd include:

  • Full-brain coverage with dense-array EEG (electroencephalographic) sensors.  Full-brain measurement is the universal neuroscientific standard applied in the world's premier laboratories and educational institutions.
  • Within seconds of slipping the user-friendly headset on, a consumer's brainwave activity is captured across the full cortex.
  • Wireless transmission of brainwave signals; capable of interfacing with any Bluetooth-enabled mobile communications device.
  • Dry "smart" electrodes (sensors), eliminating the use of gels and enhancing signal quality by introducing novel technological breakthroughs.
  • Enables first full-brain coverage home panels for market research.
  • Comfortable, lightweight, aesthetically pleasing modular design with easily-replaceable sensors.

"Mynd represents an authentic breakthrough in brainwave measurement technology and I am especially pleased that it will also be used to help people with neurological disabilities such as paralysis overcome some of their most difficult barriers. This is a truly compelling example where a technology developed for business-to-business applications like neuromarketing can add enormous value to other avenues of life," said Dr. Robert T. Knight, Director of the Helen Wills Neuroscience Institute at the University of California, Berkeley, and NeuroFocus' Chief Science Advisor, said.

NeuroFocus will be rolling out the Mynd headset throughout its neurological testing laboratories in the U.S., the UK/Europe, the Asia/Pacific region, Latin America, and the Middle East.  The headset will also be deployed in the company's NeuroLabs, dedicated neurological testing facilities which NeuroFocus designs, builds, staffs, and operates for individual client companies.

Dr. Gerwin Schalk, Research Scientist, Wadsworth Center, Neural Injury & Repair, and developer of BCI 2000, the main technological platform used for brain-computer interaction worldwide for treatment of paralysis, cited the landmark aspect of Mynd: "This wireless dry electrode headset substantially reduces the cost and expertise necessary to access signals from the brain, which has profound implications for clinical and commercial applications of EEG technology."  

NeuroFocus Methodology

NeuroFocus employs high-density arrays of medical grade EEG sensors to measure across the full brain. Each sensor captures brainwave activity at 2,000 times a second. The company also applies eye-tracking technology to identify the location of visual focus at the pixel level.

About NeuroFocus

The world's leading neuromarketing firm, NeuroFocus ( brings advanced neuroscience knowledge and expertise to the worlds of branding, product development and packaging, in-store marketing, advertising, and entertainment. NeuroFocus clients include Fortune 100 companies across dozens of categories.

Headquartered in the U.S. and operating globally through offices and NeuroLabs in the UK and Europe, the Asia/Pacific region, Latin America, and the Middle East, the company leverages Nobel Prize caliber and Doctorate-level credentials in neuroscience and marketing from the University of California at Berkeley, MIT, Hebrew University, Harvard, Oxford, Columbia University, and other leading institutions, combined with executive business management and consulting expertise.

About TOBI

TOBI is a major European initiative which will develop practical technology for brain-computer interface (BCI) that will improve the quality of life of disabled people and the effectiveness of rehabilitation.  

SOURCE NeuroFocus
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. NeuroFocus and New Scientist Magazine Apply Neuromarketing to Select Cover Design
2. ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
3. Pharmaceutics International Inc. (Pii) Announces Appointment of Rampurna Prasad Gullapalli, Ph.D. as Vice President of Drug Delivery Technologies
4. An Improved Dry Eye Medication - ICAP Ocean Tomo Announces Auction of a New Collyrium From Aqueous Pharma Limited
5. SuperNova Diagnostics® Announces Agreement with KSB Diagnostics of China
6. Misonix Announces Change in Distribution of BoneScalpel™ Bone Cutting System in the U.S.
7. ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®s Label Claim
8. Shanghai ChemPartner Announces Being Selected as Antibody Service Partner by Shenogen Pharma Group
9. China Nepstar Chain Drugstore Announces Management Appointments
10. Nephros Announces Split Adjusted Trade Date
11. Bionovo Announces 2010 Highlights and Year-End Financial Results
Post Your Comments:
(Date:12/1/2015)... , Dec. 2, 2015  A combination of detailed ... the first time in the surgical planning for separation of ... annual meeting of the Radiological Society of North ... --> Conjoined twins, or twins whose bodies are connected, ... rates are low and separating them through surgery is extremely ...
(Date:12/1/2015)... , Dec. 1, 2015  A large study ... drug tamoxifen while taking an antidepressant found no increased ... today in The Journal of the National Cancer Institute. ... Tamoxifen is a commonly prescribed generic drug taken by ... developing a recurrence. Tamoxifen is recommended for five years, ...
(Date:12/1/2015)... Wash. and VANCOUVER , ... Committee (DMC) meeting, OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ... is continuing based on the pre-planned interim futility analysis ... review, no new safety issues were identified by the ... all analyses and final results are expected in the ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... ... and hematology continuing medical education (CME), today announced that the first annual School ... New York. , “The prevention, detection and treatment of gastrointestinal cancers are undergoing ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Growth in medical ... due to decreases in utilization of hospital and nonhospital care, according to a recent ... Medical Benchmarks for Louisiana, 16th Edition , found medical payments per claim with more ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... images have been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s ... America Annual Meeting from November 29 to December 4, 2015. , MED-TAB ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has ... the Radiological Society of North America (RSNA) 2015 annual meeting through December 3 ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... clinical solutions for the care management and population health arenas, is pleased to ... clinical and cost containment services, has successfully implemented the ACUITY Complete Care™ Management ...
Breaking Medicine News(10 mins):